We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Imagine this: a worldwide network of radio-tagged pharmaceuticals, weeding out the multi-billion dollar counterfeit drug market with a universal security system.
Federal health officials sent a warning letter to BioMarin Pharmaceutical Inc. Wednesday, saying a company Web site makes unsubstantiated claims for the liquid form of the drug Orapred, a steroid used to reduce inflammation in asthma and other conditions.
Consumers are suddenly getting a break on the cost of generic drugs as discount retailers and some prescription benefit managers start programs that provide a host of popular medications at very low costs.
Boehringer Ingelheim Pharmaceuticals Inc. said Thursday it has entered into an agreement with Johnson & Johnson and Pfizer Inc. to acquire the U.S. rights to the over-the-counter Zantac product line for $509.5 million in cash.
The NIH will award almost $700 million in research grants to 12 academic health centers between Oct. 1, 2006, and June 30, 2011, roughly $100 million of that in the nine-month period ending June 30, 2007.
The FDA announced a crackdown on two companies' marketing of unapproved drugs, including a consent decree prohibiting them from continuing the practice and a request by the agency to recall all they have already sold.
A bipartisan group of lawmakers is pressuring Senate leadership to vote on legislation establishing a federal importation protocol, citing recent regulatory and legislative changes.
NitroMed, Inc. announced a revision of its strategy and business model in a move intended to focus its resources on the accelerated development of an extended release formulation of BiDil (isosorbide dinitrate/hydralazine hydrochloride), known as BiDil XR.